Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
BioCryst Downgraded By JPMorgan, Analysts Await 'More Data'
Jim Swanson, Benzinga Staff Writer, February 09, 2016.
Astellas Names James Robinson President, Americas Operations
NORTHBROOK, Ill.
NICE says no to Praluent
Britain’s National Institute for Health and Care Excellence (NICE) has published draft guidance against prescribing the Sanofi (Euronext.
NIH researchers identify striking genomic signature shared by five types of cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Cognitive Behavioral Therapy: CBT May Change Brain Volume
New findings published in the journal Translational Psychiatry show that cognitive behavioral therapy (CBT) may help in changing brain volume.
Boehringer Ingelheim launches Spiriva Respimat in US market for maintenance treatment of asthma in adults & adolescents
Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, announced that Spiriva Respimat is now available for the treatment of asthma by prescription in US pharmacies.
Blood pressure pills may improve autism patients' social skills
New York.
Bowing to pressure, FDA to reform painkiller approval process
Bowing to pressure from lawmakers, Dr.
Bayer’s prostate cancer drug recommended by NICE
The UK's National Institute for Health and Care Excellence (NICE) has issued its final guidance recommending German pharma major Bayer’s (BAYN.
AstraZeneca Wins European Approval for Lung Cancer Drug Tagrisso
AstraZeneca on Wednesday said European regulators have approved a potential blockbuster lung cancer drug that the company hopes will form a key plank of its growth plans.
Coffee may protect against liver cirrhosis
Drinking coffee every day is linked to a reduced risk of liver cirrhosis, according to a new review of published evidence that also suggests drinking two extra cups a day may nearly halve the risk of ...
Eagle Pharmaceuticals Announces Commercial Availability of Docetaxel Injection, Non-Alcohol Formula
WOODCLIFF LAKE, N.
638
639
640
641
642
643
644
645
646
